Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Monoethanolamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Monoethanolamine SCHEMBL12208272 | 0.80 | — | — | |
| Ethylene Glycol SCHEMBL2307225 | 0.72 | — | — | |
| Ethylenediamine SCHEMBL1331150 | 0.72 | — | — | |
| SCHEMBL13750804 | 0.70 | — | — | |
| Monoethanolamine SCHEMBL13534425 | 0.70 | — | — | |
| Ethylenediamine SCHEMBL1330814 | 0.67 | — | — | |
| SCHEMBL4957834 | 0.65 | — | — | |
| SCHEMBL19053 | 0.65 | — | — | |
| 1,3-Propanediol SCHEMBL3133442 | 0.63 | — | — | |
| 1,4-Butanediol SCHEMBL2537863 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4739652-A1 | LIPIDS AND COMPOSITIONS THEREOF | Kernal Biologics, Inc. (US) | 2026-05-13 | — | — | EP | disclosed |
| WO-2025010290-A1 | LIPIDS AND COMPOSITIONS THEREOF | KERNAL BIOLOGICS, INC. (US) | 2025-01-09 | — | — | WO | disclosed |
| EP-3998260-B1 | SGC STIMULATORS | CYCLERION THERAPEUTICS INC (US) | 2023-11-01 | — | — | EP | disclosed |
| US-20230106002-A1 | sGC STIMULATORS | IRONWOOD PHARMACEUTICALS, INC. | 2023-04-06 | — | — | US | disclosed |
| CN-110016020-B | Compound or pharmaceutically acceptable salt thereof, application and pharmaceutical composition thereof | 赛克里翁治疗有限公司 | 2022-07-26 | — | — | CN | disclosed |
| EP-3998260-A1 | SGC STIMULATORS | Cyclerion Therapeutics, Inc. (US) | 2022-05-18 | — | — | EP | disclosed |
| WO-2022072634-A1 | BICYCLIC COMPOUNDS FOR USE IN THE TREATMENT CANCER | SCORPION THERAPEUTICS, INC. (US) | 2022-04-07 | — | — | WO | disclosed |
| US-11267804-B2 | (R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity | JANSSEN PHARMACEUTICA NV (BE) | 2022-03-08 | — | — | US | disclosed |
| EP-3660013-B1 | SGC STIMULATORS | CYCLERION THERAPEUTICS INC (US) | 2022-01-19 | — | — | EP | disclosed |
| US-11207323-B2 | sGC stimulators | CYCLERION THERAPEUTICS, INC. (US) | 2021-12-28 | — | — | US | disclosed |
| US-20120129849-A1 | DEUTERATED SERINE-THREONINE PROTEIN KINASE MODULATORS | CYLENE PHARMACEUTICALS, INC. (US) | 2012-05-24 | — | — | US | disclosed |
| US-20110282587-A1 | COMPUTER READABLE STORAGE MEDIUMS, METHODS AND SYSTEMS FOR NORMALIZING CHEMICAL PROFILES IN BIOLOGICAL OR MEDICAL SAMPLES DETECTED BY MASS SPECTROMETRY | EMORY UNIVERSITY (US) | 2011-11-17 | — | — | US | disclosed |
| WO-2011059610-A1 | BENZENE SULFONAMIDE THIAZOLE AND OXAZOLE COMPOUNDS | GLAXOSMITHKLINE LLC (US) | 2011-05-19 | — | — | WO | disclosed |
| US-7425451-B2 | Triazine derivatives as universal peptide isotope tag reagents (U-PIT) | AGILENT TECHNOLOGIES, INC. (US) | 2008-09-16 | — | — | US | disclosed |
| US-20070031973-A1 | Triazine derivatives as universal peptide isotope tag reagents (U-PIT) | ROBOTTI KARLA M | 2007-02-08 | — | — | US | disclosed |
| US-7109040-B2 | Modular isotope coding approach to proteomic analysis | AGILENT TECHNOLOGIES, INC. (US) | 2006-09-19 | — | — | US | disclosed |
| US-20050100956-A1 | Modular isotope coding approach to proteomic analysis | AGILENT TECHNOLOGIES, INC. | 2005-05-12 | — | — | US | disclosed |
| US-20040115821-A1 | Triazine derivatives as universal peptide isotope tag reagents (U-PIT) | AGILENT TECHNOLOGIES, INC. | 2004-06-17 | — | — | US | disclosed |
| EP-1429147-A1 | Universal reagent for isotopically tagging peptides | Agilent Technologies, Inc. (US) | 2004-06-16 | — | — | EP | disclosed |
| EP-1429146-A1 | Proteomic analysis | Agilent Technologies, Inc. (US) | 2004-06-16 | — | — | EP | disclosed |